Patent ID: 11873320
Assignee: REATA PHARMACEUTICALS HOLDINGS, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A method of treating a condition associated with inflammation or oxidative stress in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of the pharmaceutical composition comprising an active ingredient comprising a polymorphic form of a compound having the formula:, wherein the polymorphic form is crystalline, having an X-ray powder diffraction pattern (CuKα) comprising peaks at about (a) 10.601, 11.638, 12.121, 13.021, 13,435, 15.418, 15.760, 17.830, 18.753, and 19.671 °2θ, or (b) 7.552, 10.339, 11.159, 12.107, 14.729, 15.329, 15.857, 16.824, 17.994, 18.344, 19.444, 19.764, 20.801, and 22.414 °2θ; and
a pharmaceutically acceptable carrier,
wherein the condition is a skin disease or disorder selected from the group consisting of dermatitis, a chronic wound, alopecia, vitiligo, hyperkeratosis, and psoriasis.